
Xinyu Peng
Articles
Development of Human Monoclonal Antibodies With Broad Reactivity for Rabies Postexposure Prophylaxis
Nov 27, 2024 |
onlinelibrary.wiley.com | Meng Wu |Xinyu Peng |Weidi Xu |Hao Zhang
1 Introduction Human rabies, caused by RABV, is an acute progressive viral encephalomyelitis with almost 100% fatality following the onset of symptoms and 59 000 people are estimated to die each year, which mainly occurs in Africa and Asia, and 40% are in children [1]. Although rabies can be controlled in the animal reservoirs through mass vaccination and prevented through the appropriate prophylactic treatment in humans exposed to the virus.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →